Anxiety

Understanding Emotions and Decision-Making

  • Importance of emotions, prefrontal cortex (PFC), and amygdala in decision-making.

  • The PFC orchestrates thought and action in alignment with internal goals by aggregating sensory information, memory retrieval, and emotional evaluations.

  • Damage to the orbital and medial prefrontal cortex affects rational thinking and emotions, leading to impaired decision-making.

    • Example: Phineas Gage exhibited a personality change after sustaining damage to the medial forebrain.

  • The amygdala plays a crucial role in appraising social circumstances, influencing feelings like trust and empathy, often subconsciously shaped by personal experiences.

    • Example: A person may dislike someone who resembles a former acquaintance due to implicit bias.

  • Psychopaths show reduced activity in the amygdala and medial frontal cortex (Miller, 2008, Science 321:1284), leading to questions about whether this is due to amygdala impairment or attention issues.

Anxiety Disorders

  • Definition: Anxiety disorders encompass conditions such as panic attacks, post-traumatic stress disorder (PTSD), generalized anxiety disorder, and obsessive-compulsive disorder (OCD).

  • Statistics: Rates of anxiety disorders among American teenagers have doubled since 2008, possibly due to increasing financial stress and heightened digital device usage.

  • Risk Factors: Higher stress levels during childhood in low-income families correlate with a greater likelihood of anxiety disorders and depression in adulthood.

    • Mechanism: Early life stress may decrease glucocorticoid receptor expression in the hippocampus, negatively affecting the stress response.

  • HPA Axis: Involves the following chain of events:

    • Amygdala → hypothalamus → Corticotropin-Releasing Hormone (CRH) → Adrenocorticotropic Hormone (ACTH) → cortisol (from the pituitary to adrenal gland).

    • Feedback loop activates glucocorticoid receptors in the hippocampus and inhibits the stress response.

    • Gene expression of glucocorticoid receptors is influenced by early experiences, indicating a biological basis for stress response alteration.

  • Alcohol Use and Anxiety: Individuals with anxiety disorders may abuse alcohol because:

    • Alcohol increases GABA receptor activity, inhibiting neuron activity associated with anxiety, resembling the effects of benzodiazepines.

    • This leads to a cycle where individuals with anxiety seek alcohol for its anxiolytic effects.

Affective Disorders

  • Definition: Affective disorders include major depression and manic depression characterized by abnormal sadness, feelings of worthlessness, disordered sleep and eating, poor concentration, a lack of interest in daily activities, and suicidal thoughts.

  • Diagnosis of Major Depression: Requires symptoms to persist for more than two weeks and disrupt social or occupational functioning.

  • Therapeutic Treatments:

    • SSRIs (Selective Serotonin Reuptake Inhibitors): Commonly prescribed, effectiveness increases when combined with counseling, but takes weeks to show effects.

    • Electroconvulsive shock therapy (ECT): Highly effective, particularly for severe cases.

    • Exercise: Found to be as effective as SSRIs in improving symptoms.

    • Counseling: May involve sleep improvement interventions if necessary.

    • Potential new treatments include:

    • Transcranial Magnetic Stimulation (TMS) targeting lateral prefrontal areas.

    • Psilocybin and other 5-HT2A agonists showing rapid efficacy affecting the medial prefrontal cortex.

    • Ketamine: Produces effects within two hours and lasts a week; it blocks NMDA receptors and HCN1 K+ channels, enhancing glutamate neurotransmission.

  • Causes of Depression:

    • Risk factors include genetics, stressful life events, and more.

    • Various neurochemical abnormalities are postulated, involving:

    • Serotonin (5-HT) levels and their role in mood regulation.

    • Medial prefrontal cortex overactivity and its implications.

    • Other neurotransmitter systems (dopamine, glutamate).

    • Early life experiences impacting long-term mental health.

    • Hormonal imbalances related to the HPA axis, including CRH and cortisol dysregulation.

    • Abnormal cognitive styles, such as negative thinking.

    • Dysfunction in the brain's reward system, particularly the role of dopamine affected by SSRIs and psychedelics.

  • Resilience factors contribute to individual differences in stress response.

Treatment Comparisons

  • Treatment for anxiety disorders often achieves higher success rates, especially when specific triggers are identifiable:

    • Counseling/Psychotherapy: Directly addresses anxiety triggers by helping patients reframe their associations with anxiety-provoking situations, often through gradual exposure.

    • Drug Targets: More is known regarding potential drug treatments for anxiety, including GABA receptor blockers and other alternatives to SSRIs, contributing to better outcomes compared to depression treatments.

  • Depression Complexity: Depression typically lacks specific identifiable triggers, making treatment and understanding more complex, with numerous possible pathways contributing to its presentation.